CLCS

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Verified Company Profile 5/02/2017
Contact Info
  • 5 Kineret Street
  • Bnei Brak 5126237
  • Israel

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001569340
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 50 a/o Apr 28, 2015
Company Officers/Contacts
Itamar Shimrat President, CEO, CFO
Company Directors
Dennis Brown Chairman
Yoram Drucker
Ben Friedman
Itamar Shimrat
David Zolty
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States
 
Securities Counsel
Sichenzia Ross Ference Kesner LLP OTCQX Sponsor
61 Broadway
32nd Floor
New York, NY, 10006
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Ticket To See Inc. until 6-2014
CLCS Security Details
Share Structure
Market Value1 $7,817,362 a/o Jun 21, 2017
Authorized Shares 200,000,000 a/o Sep 30, 2016
Outstanding Shares 24,429,256 a/o Nov 15, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 5,620,428 a/o Apr 20, 2016
Par Value 0.001
Transfer Agent(s)
Globex Transfer, LLC
Shareholders
Shareholders of Record 76 a/o Apr 20, 2016
Short Selling Data
Short Interest 524 (133.93%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security